316 related articles for article (PubMed ID: 32065287)
21. PET/CT and MRI for Identifying Axillary Lymph Node Metastases in Breast Cancer Patients: Systematic Review and Meta-Analysis.
Zhang X; Liu Y; Luo H; Zhang J
J Magn Reson Imaging; 2020 Dec; 52(6):1840-1851. PubMed ID: 32567090
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer.
Liu T; Cheng T; Xu W; Yan WL; Liu J; Yang HL
Skeletal Radiol; 2011 May; 40(5):523-31. PubMed ID: 20495798
[TBL] [Abstract][Full Text] [Related]
23. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
Michielsen K; Vergote I; Op de Beeck K; Amant F; Leunen K; Moerman P; Deroose C; Souverijns G; Dymarkowski S; De Keyzer F; Vandecaveye V
Eur Radiol; 2014 Apr; 24(4):889-901. PubMed ID: 24322510
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.
Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG
J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685
[TBL] [Abstract][Full Text] [Related]
25. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
26. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.
Zhou J; Gou Z; Wu R; Yuan Y; Yu G; Zhao Y
Skeletal Radiol; 2019 Dec; 48(12):1915-1924. PubMed ID: 31127357
[TBL] [Abstract][Full Text] [Related]
27. Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
Kim K; Kim SJ
Leuk Res; 2020 Dec; 99():106475. PubMed ID: 33189988
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
Li B; Li Q; Nie W; Liu S
Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Qu X; Huang X; Yan W; Wu L; Dai K
Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
[TBL] [Abstract][Full Text] [Related]
30. MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
Liang X; Yu J; Wen B; Xie J; Cai Q; Yang Q
Clin Radiol; 2017 Apr; 72(4):295-301. PubMed ID: 28139203
[TBL] [Abstract][Full Text] [Related]
31. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT.
Liu T; Wang S; Liu H; Meng B; Zhou F; He F; Shi X; Yang H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):457-465. PubMed ID: 27752772
[TBL] [Abstract][Full Text] [Related]
32.
Petersen LJ; Nielsen JB; Langkilde NC; Petersen A; Afshar-Oromieh A; De Souza NM; De Paepe K; Fisker RV; Arp DT; Carl J; Haberkorn U; Zacho HD
World J Urol; 2020 Apr; 38(4):939-948. PubMed ID: 31190153
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using
Greuter MJ; Schouten CS; Castelijns JA; de Graaf P; Comans EF; Hoekstra OS; de Bree R; Coupé VM
BMC Cancer; 2017 Apr; 17(1):256. PubMed ID: 28399836
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing
Barabasch A; Heinzel A; Bruners P; Kraemer NA; Kuhl CK
Radiology; 2018 Sep; 288(3):764-773. PubMed ID: 29786487
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
37. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.
de Bondt RB; Nelemans PJ; Hofman PA; Casselman JW; Kremer B; van Engelshoven JM; Beets-Tan RG
Eur J Radiol; 2007 Nov; 64(2):266-72. PubMed ID: 17391885
[TBL] [Abstract][Full Text] [Related]
38. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
[TBL] [Abstract][Full Text] [Related]
39. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.
Guo Y; Wang L; Hu J; Feng D; Xu L
PLoS One; 2018; 13(9):e0203400. PubMed ID: 30192819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
